Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / first-rfp-to-vantage.docx
first-rfp-to-vantage.docx
Parties
LLC Plaintiff Penterra Pharmaceuticals Corp
Harkness LLP
Penterra Pharmaceuticals Corp
Meridian Services Inc
Polk LLP
Plaintiff Penterra Pharmaceuticals Corp
M. Rourke
Dates
August 9, 2021
July 1, 2017
January 12, 2018
January 1, 2016
January 1, 2018
March 31, 2018
September 14, 2020
September 1, 2020
May 14, 2021
March 8, 2021
Amounts
$6.4
$11.2
$14.8
$18.3
$16.1
$9.5
$35
$148
$67
Obligations
DEFINITIONS As used herein, the following terms shall have the meanings set forth below
"Products" means Oncalaris® (pegvisomant-axel), in 20 mg and 40 mg vial dosage forms, and Renuvesta® (cilosporin-beta), in 5 mg capsule dosage form, as those products are identified and defined in the Agreement, and shall include all lots, batches, and units of such products, regardless of National Drug Code (NDC) number or packaging configuration
To the extent any Instruction conflicts with a specific direction contained in an individual Request, the specific direction shall control
Where a Request specifies a narrower or different time period, that specified time period shall govern with respect to that Request only
Defendant shall produce all responsive Documents and things that are in its possession, custody, or control, regardless of where such Documents are physically located
If responsive Documents are in the possession of a third party over whom Defendant has a legal right to obtain such Documents, or who would provide them upon request, Defendant shall obtain and produce such Documents